Skip to content

French Validation Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ) Questionnaire

Validation of a French Translation of the Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ): A Prospective One-year Follow-up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00706043
Enrollment
100
Registered
2008-06-27
Start date
2008-06-30
Completion date
2012-12-31
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Low Back Pain, Chronic Low Back Pain

Keywords

Low back pain

Brief summary

Low back pain is a very common disease. Among the persons suffering of acute low back pain, about 10% are at risk of developping chronic pain. A screening questionnaire assessing this risk has been developed and validated in Swedish and English (Orebro Musculoskeletal Pain Screening Questionnaire, Linton, 2003). The aim of our study is to validate a french translation of this questionnaire. Patients suffering from acute low back pain will be asked to fill in several questionnaires at day 0, and 6 and 12 month later.

Interventions

None listed

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* all consecutive patients presenting at the clinical care setting with acute low back pain * pain lasting for less than three months * cumulated sick leave less thant six months

Exclusion criteria

* unability to sufficiently read and understand French * presence of red flags as according to the New Zealand Acute Low Back Pain Guide

Design outcomes

Primary

MeasureTime frame
Pain6 and 12 month

Secondary

MeasureTime frame
Professional status6 and 12 months
functional status6 and 12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026